OpenAlex
PricingAboutJobs
Log inGet started
Work

Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation

HTML

Year: 2017
Type: article
Study design: Observational Study
Source: Blood
DOI: 10.1182/blood-2017-05-783225
Authors: Kate J. Newberry, Keyur Patel, Lucia Masarova, Rajyalakshmi Luthra, Taghi Manshouri, Elias Jabbour, Prithviraj Bose, Naval Daver, Jorge Cortes, Hagop Kantarjian, Srdan Verstovsek
Institution: The University of Texas MD Anderson Cancer Center
Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: myelofibrosis, ruxolitinib, clonal evolution, drug discontinuation, survival, transfusion dependence, prognostic factors, platelet count, JAK inhibitors
SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2731573311
FWCI: 13.97
Cites: 15
Cited by: 233
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security